Biotalys (formerly AgroSavfe)
Developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply.
Launch date
Employees
Market cap
€100m
Enterprise valuation
€89m (Public information from Sep 2024)
Share price
€3.1 BTLS.BR
Company register number 0508.931.185
Ghent East Flanders (HQ)
Financials
Estimates*
| EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | - | - | 3.0m | 3.0m | 3.0m |
| EBITDA | (12.3m) | (16.5m) | (20.9m) | (18.5m) | (8.8m) | (9.0m) | (9.2m) |
| % EBITDA margin | - | - | - | - | (293 %) | (300 %) | (307 %) |
| Profit | (10.7m) | (16.9m) | (22.7m) | (20.5m) | (11.5m) | (12.4m) | (13.8m) |
| % profit margin | - | - | - | - | (383 %) | (413 %) | (460 %) |
| EV / revenue | - | - | - | - | 29.3x | 33.8x | 39.0x |
| EV / EBITDA | - | -10.3x | -8.6x | -8.1x | -10.0x | -11.3x | -12.7x |
| R&D budget | 11.5m | 13.9m | 18.8m | 16.6m | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Spinout | ||
€5.0m | Series A | ||
* | $8.7m | Series B | |
* | $11.6m | Series B | |
* | €35.0m | Series C | |
* | €10.0m | Series C | |
€1.6m | Grant | ||
€1.1m | Grant | ||
| N/A | $54.6m | IPO | |
| Total Funding | €71.2m | ||
Related Content
Recent News about Biotalys (formerly AgroSavfe)
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.